These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7235674)

  • 41. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and drug resistance characteristics of
    Liu J; Wang R; Fang M
    J Int Med Res; 2020 Oct; 48(10):300060520962296. PubMed ID: 33081537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia.
    Barl P; Bedenić B; Sardelić S; Uzunović S; Vraneš J; Plečko V
    Med Glas (Zenica); 2012 Aug; 9(2):317-24. PubMed ID: 22926370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Nationwide study of the antimicrobial susceptibility of clinical isolates of Proteus group in Japan].
    Igari J; Shitara M; Morimoto M; Shiga N; Kosakai N
    Jpn J Antibiot; 1987 Apr; 40(4):823-42. PubMed ID: 3475483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of resistance of Providencia stuartii to multiple antibiotics: speciation and biochemical characterization of Providencia.
    Overturf GD; Wilkins J; Ressler R
    J Infect Dis; 1974 Mar; 129(3):353-7. PubMed ID: 4493148
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility.
    Mao YC; Chang CL; Huang YC; Su LH; Lee CT
    J Microbiol Immunol Infect; 2018 Apr; 51(2):214-219. PubMed ID: 27553450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transferable gentamicin-tobramycin resistance in nosocomial strains of Proteus rettgeri from oncologic patients.
    Elanová E; Balogová O; Krcméry V
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):411-3. PubMed ID: 1015026
    [No Abstract]   [Full Text] [Related]  

  • 52. Resistance to gentamicin: a growing concern.
    Siebert WT; Moreland NJ; Williams TW
    South Med J; 1977 Mar; 70(3):289-92. PubMed ID: 322294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transferable urease activity in Providencia stuartii.
    Grant RB; Penner JL; Hennessy JN; Jackowski BJ
    J Clin Microbiol; 1981 Mar; 13(3):561-5. PubMed ID: 7240389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin.
    Jones RN; Fuchs PC; Sommers HM; Gavan TL; Barry AL; Gerlach EH
    Antimicrob Agents Chemother; 1980 Apr; 17(4):750-6. PubMed ID: 6446880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.
    Stephens M; Potten M; Bint AJ
    Infection; 1979; 7(3):109-12. PubMed ID: 478651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.
    Meyers BR; Hirschman SZ
    Antimicrob Agents Chemother; 1977 Jan; 11(1):118-21. PubMed ID: 836009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials.
    Lockwood WR; Lawson LA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):281-4. PubMed ID: 4202342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. R plasmids in gentamicin-tobramycin-carbenicillin-resistant nosocomial strains of Proteus rettgeri and Proteus morgani.
    Výmola M; Zahradnický J; Krcméry V; Trojanová M; Chaloupecký V
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(3):382-14. PubMed ID: 570994
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.